SCM
TECH icon

SG Capital Management’s Bio-Techne TECH Stock Holding History

SG Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,218,299
Closed -$63.7M – 118
2026
Q1 		$63.7M Buy
1,218,299
+69,170
+6% +$4.15M 4.23% 1
2025
Q4 		$67.6M Buy
+1,149,129
New +$69.8M 6.49% 2
2024
Q4 		– Sell
-2,767
Closed -$221K – 90
2024
Q3 		$221K Buy
+2,767
New +$208K 0.03% 58
2017
Q3 		– Sell
-820,220
Closed -$24.1M – 74
2017
Q2 		$24.1M Buy
+820,220
New +$22.4M 4.28% 6

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SG Capital Management's TECH Position: Q2 2026 in Review

SG Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 1,218,299 shares — an estimated $63.7M sold.

SG Capital Management first reported a position in TECH in Q2 2017 and held it in 4 quarters. The position peaked at $67.6M in Q4 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • SG Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • SG Capital Management sold 1,218,299 Bio-Techne shares in Q2 2026, an estimated $63.7M.
  • SG Capital Management first reported a position in Bio-Techne in Q2 2017 and held it in 4 quarters.
  • SG Capital Management's Bio-Techne position peaked at $67.6M in Q4 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on SG Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.